Percutaneous ethanol injection in benign thyroid nodules

Efficacy of percutaneous ethanol injection in benign cystic and mixed thyroid nodules: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240718062461N1

Enrollment

Registered

2024-08-04

Start date

2020-06-04

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign thyroid nodules. Nontoxic single thyroid nodule

Interventions

Intervention 1: Intervention group: Patients treated with ablation therapy technique including subcutaneous injection of 99% ethanol will be guided by ultrasound. The procedure will be performed by a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with benign cystic and predominantly cystic thyroid nodules Patients with a minimum age of 18 years

Exclusion criteria

Exclusion criteria: Patients confirmed or suspected of thyroid cancer Patients suspected of Covid-19 infection Patients with a history of hypersensitivity reaction to methanol Pregnant women

Design outcomes

Primary

Measure	Time frame
Thyroid nodules size changes in ultrasonography. Timepoint: Measurement of the thyroid nodules size at baseline and at sixth months following treatment. Method of measurement: Measurement of thyroid nodules size using ultrasound based on ellipsoid formula.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazal Mohseni

Mazandaran University of Medical Sciences

mohseni.ghazal@yahoo.com+98 11 3448 4864

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026